Panminerva Medica

Papers
(The H4-Index of Panminerva Medica is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
At the peak of COVID-19 age and disease severity but not comorbidities are predictors of mortality: COVID-19 burden in Bergamo, Italy31
Biobanking for COVID-19 research29
Pattern of Emergency Department referral during the COVID-19 outbreak in Italy25
Noninvasive biomarkers in predicting nonalcoholic steatohepatitis and assessing liver fibrosis: systematic review and meta-analysis23
Genetic associated complications of type 2 diabetes mellitus23
Physical and psychological sequelae at three months after acute illness in COVID-19 survivors21
MiR-21-5p reduces apoptosis and inflammation in rats with spinal cord injury through PI3K/AKT pathway21
MiR-30d inhibits cardiomyocytes autophagy promoting ferroptosis after myocardial infarction20
An update on the pathophysiology of acute and recurrent pericarditis18
The early identification of alcohol use disorders and liver injury: proposal for a diagnostic algorithm17
Circular RNA circRHOBTB3 inhibits ovarian cancer progression through PI3K/AKT signaling pathway16
The URRAH study15
Impact of anabolic androgenic steroids on male sexual and reproductive function: a systematic review15
The vaccine journey for COVID-19: a comprehensive systematic review of current clinical trials in humans14
0.046828985214233